Sirius Investors

EVBG Financial Statements & Analysis

Complete financial statements for EVBG including income statement, balance sheet, and cash flow statement. Analyze EVBG's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

Financial Health Score

Financial Health Score

74
Good
Poor (0-40)Neutral (40-60)Good (60-100)

Income Statement

Revenue
3.9%
Net Income
22.7%
Gross Margin
-7.7%
Operating Margin
36.3%

Balance Sheet

Current Ratio
-44.5%
Debt to Equity
-27.3%
Asset Turnover
14.0%

Cash Flow

Operating Cash Flow
259.9%
Net Cash Flow
73.8%
Free Cash Flow
2998.7%
Cash Flow to Debt
373.6%

Income Statement Comparison

Revenue & Net Income

Period Comparison

Metric20222023ChangeImpact
Revenue431.89M448.79M3.9%
Gross Profit296.96M284.92M4.1%
Operating Income-72014000-4764800033.8%
Net Income-61174000-4730500022.7%
EPS-1.54-1.1624.7%
EBITDA12.28M11.17M9.1%
Gross Margin68.76%63.49%7.7%
Operating Margin-16.67%-10.62%36.3%
Net Income Margin-14.16%-10.54%25.6%
R&D Expenses95.99M91.17M5.0%

Income Statement Full Table

Metric20232022202120202019
Revenue448.79M431.89M368.43M271.14M200.88M
Gross Profit284.92M296.96M254.22M188.11M137.35M
Operating Income-47648000-72014000-76249000-72214000-47228000
Net Income-47305000-61174000-94796000-93396000-52250000
EPS-1.16-1.54-2.5-2.7-1.58
EBITDA11.17M12.28M-25439000-40369000-27007000
Gross Margin63.49%68.76%69.00%69.38%68.37%
Operating Margin-10.62%-16.67%-20.70%-26.63%-23.51%
Net Income Margin-10.54%-14.16%-25.73%-34.45%-26.01%
R&D Expenses91.17M95.99M81.65M62.51M50.02M

Our detailed financial analysis helps investors understand EVBG's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track EVBG's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.